Tiragolumab and atezolizumab

DRUG2 trials

Sponsors

University Medical Center Groningen, Hoffmann-La Roche

Conditions

CancerHead and Neck NeoplasmsMSI-H CancerMelanoma

Phase 2

Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors

RecruitingNCT05483400

University Medical Center GroningenHead and Neck Neoplasms, Melanoma, MSI-H Cancer

Start: 2023-10-18End: 2027-09-30Target: 97Updated: 2025-03-30

Phase 3

A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study

RecruitingNCT05862285

Hoffmann-La RocheCancer

Start: 2023-06-01End: 2033-03-01Target: 100Updated: 2026-03-13